Grifols SA Barcelona

(GIFLF)

By |

Profile

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Contact Information

Website: www.grifols.com
Email: inversores@grifols.com
Main Phone: +34 935710500
Address: Avinguda de la Generalitat, 152-158
Address 2: Parque empresarial Can Sant Joan
City / Town: Barcelona
Country: ESP
Postal Code: 08174

Issuer Information

Exchange: OTO
CEO: Raimon Grifols Roura / Víctor Grifols Deu
Employees: 18296
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 26.75 $ -2.3713 (-8.14%)
Last Price 26.75 Change $ -2.3713 Change % -8.14 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 26.75 High 26.75 Low 26.75 Prev Close 29.12
Last Trade Volume 100 52 Wk Hi 32.20 52 Wk Low 25.40
Market Cap 18.3 bi Ex-Div Date Div Rate 0.46 Yield 1.7040
Shares 683,737,763.00 EPS (TTM) 1.24 PE Ratio 23.70 Exchange OTCPK